Verve Therapeutics Verve Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease. | Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders. | Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. | AID Genomics AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer. | The DNA Company The DNA Company is a provider of functional genomics solutions for health and wellness. | |
Founding Date | Founding Date 2018 | Founding Date 2015 | Founding Date 2007 | Founding Date 2013 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Newton, US HQ Needham, US | Locations Rehovot, IL HQ | Locations Mississauga, CA HQ Mississauga, CA |
Employees | Employees 70 | Employees 166 | Employees 592% decrease | Employees 58 | Employees 21 |
Valuation ($) | Valuation ($) 506.9 m | Valuation ($) 380.1 m | Valuation ($) 18.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $400k (Y, 2020) |
Net income | Net income ($200.1m) (FY, 2023) | Net income ($150.7m) (FY, 2022) | Net income ($52.5m) (FY, 2021) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 152.5m | Total funding raised $ 310.7m | Total funding raised $ 100m | Total funding raised N/A | Total funding raised N/A |